Pirfenidone for the treatment of bronchiolitis obliterans syndrome related to chronic graft-versus-host disease.

Blood Adv · 2025 · PMC12516044 · PMID 40554417

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

a trend toward significanceP = .060so close (0.05 < p ≤ 0.1)

Composite regression lines of responders before and during trial revealed a positive slope in ppFEV 1 with a trend toward significance ( Figure 3 C; P = .060).

also in 2,066 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.